Is trimodal therapy the current standard for muscle-invasive bladder cancer?

Objective: The aim of this review is to summarize the current evidence and future perspectives of bladder-sparing treatment for MIBC.

Methods: A non-systematic literature search in Medline/Pubmed was performed in October 2023 with the following keywords "bladder cancer", "bladder-sparing", "trimodal therapy", "chemoradiation", "biomarkers", "immunotherapy", "neoadjuvant chemotherapy", "radiotherapy".

Results: Urology guidelines recommend radical cystectomy as the standard curative treatment for muscle-invasive urothelial bladder cancer, reserving radiotherapy for patients who are unfit or who want to preserve their bladder.

Solitary Fibrous Tumor of the Urinary Bladder Associated with Hypoglycemia: An Unusual Case of Doege-Potter Syndrome.

Solitary fibrous tumors (SFT) are rare mesenchymal tumors, mostly benign. Less than 30 cases have been described for the urinary bladder, 2 of them malignant. These lesions show infrequent clinical and radiological usual features, making the diagnosis difficult.

[Therapeutic compliance in patients with renal lithiasis and biochemical risk factors.].

Objective: To evaluate patient compliance with treatment for urinary lithiasis and to detect differences in adherence, causes of this behavior and associated factors.

Methods: We performed a retrospective study of 93 patients with positive urinary metabolic study (UMS) for lithogenic pathology, diagnosed between 2013 and 2015, gathering data from the digital medical records and a structured telephonic questionnaire in 75 of them. Results were analyzed using the X2 test.

Evaluation of the Spanish Urological Association quality care indicators in a kidney transplantation programme.

Introduction: Indicators show the presence of a phenomenon and its intensity. They assess the level of quality care and identify potential situations for improvement. Our objective is to assess the 2013 and 2014 quality care indicators of our department's kidney transplantation area.

Conservative treatment of de novo renal carcinoma on kidney graft.

Background: De novo renal carcinoma in kidney transplants is an uncommon but not exceptional condition and is of significant importance due to the potential for recipient mortality and graft loss. The aim of our study was to determine the management and outcome of these tumors in our Kidney Transplantation Unit.

Material And Methods: We analyzed cases of de novo kidney tumors among patients who underwent transplantation in the last 17 years in our Kidney Transplantation Unit.